Diagnosis and Empirical Treatment of Urinary Tract Infections in Urologic Outpatients.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2020
Historique:
received: 31 01 2020
accepted: 13 03 2020
pubmed: 19 5 2020
medline: 23 4 2021
entrez: 19 5 2020
Statut: ppublish

Résumé

Due to a continuing increase of bacterial resistance in common uropathogens, we wanted to revisit our standards for the diagnosis and treatment of lower urinary tract infections, in the setting of urological outpatient care in a conurbation in Germany. All subjects presenting with significant bacteriuria at our urology clinics in Mülheim, Germany, in 2011 were included. Comorbidity, bacterial species, urinary tract symptoms, and empirically prescribed antibiotics were taken from the patients' records. In 2011, a total of 1,324 patients were included (793 female, 531 male). Of the 771 patients with symptomatic bacteriuria, 647 received antibiotic treatment, as well as 116 of 409 patients with asymptomatic bacteriuria. Escherichia coli was identified in 60% of the included patients. In 427 E. coli infections, bacterial resistance was found in 14% of 316 cases treated with quinolone, in 21% of 53 cases treated with co-trimoxazole, and in only 3% of 58 cases treated with nitrofurantoin. We found a high use of fluoroquinolones for empirical first-line antibiotics in the treatment of lower urinary tract infections. In our regional setting, antibiotic stewardship needs to be promoted, along national and international guidelines, to avoid unnecessary prescription of fluoroquinolones for empirical treatment.

Identifiants

pubmed: 32422639
pii: 000507267
doi: 10.1159/000507267
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

617-624

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Andreas Eisenhardt (A)

Urologic Outpatient Clinic PURR, Mülheim an der Ruhr, Germany, a.eisenhardt@pur-r.de.
Department of Urology, University Hospital Essen, Essen, Germany, a.eisenhardt@pur-r.de.

Katharina Schneider (K)

Urologic Outpatient Clinic PURR, Mülheim an der Ruhr, Germany.
Department of Urology, University Hospital Essen, Essen, Germany.

Herbert Hirche (H)

Institute of Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, Essen, Germany.

Hildegard Lax (H)

Institute of Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, Essen, Germany.

Boris Hadaschik (B)

Department of Urology, University Hospital Essen, Essen, Germany.

Christian Rehme (C)

Department of Urology, University Hospital Essen, Essen, Germany.

Jan D van Gool (JD)

Institute of Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH